VVested
US Investing··10 min read·Reviewed May 2026

How to buy Applied Materials (AMAT) stock from India

Buy Applied Materials (AMAT) from India legally via the LRS, in INR. The leading wafer-fab-equipment vendor — AI capex, India's Tata-PSMC and Micron Sanand fab buildout, and Section 112 are what actually decide your outcome.

Share:XLinkedInWhatsApp

Yes, an Indian resident can buy Applied Materials — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. The 90% that decides your outcome is tax, estate-tax exposure, position sizing, and whether you actually want a single cyclical semi-cap-equipment name versus a basket. AMAT pays a modest dividend, so the 25% US withholding and Form 67 paperwork do apply — just at small amounts. This is the short version.

Live data via TradingView, in USD and possibly delayed. Shown for information only — not a quote, recommendation, or investment advice.

Wall Street analyst consensus — Applied Materials

Loading live consensus…

Live Wall Street analyst data via Finnhub. Refreshed at most once every 10 minutes. Analyst views change frequently; these are not Vested.blog recommendations. For information only — not investment advice.

Recent news — Applied Materials

Live news feed via TradingView. For information only.

Financials — Applied Materials

Historical financial data via TradingView. For Wall Street analyst consensus and price targets, see your broker, Yahoo Finance, or the company's investor-relations page. For information only.

The 30-second version

  • Legal and simple. Buy AMAT via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Whole shares or a fractional rupee amount.
  • Capital-gains plus a thin dividend. AMAT's dividend yield runs near 1%; useful, not the reason to own it. The real story is the wafer-fab-equipment (WFE) cycle — deposition, etch, inspection, advanced packaging.
  • India tax: hold more than 24 months and pay 12.5% LTCG (no indexation); sell sooner and pay your slab rate. This is Section 112, not the friendlier 112A that Indian shares get.
  • Dividend friction: US withholds 25% under the India-US DTAA (file W-8BEN at onboarding). Claim Foreign Tax Credit via Form 67 with your ITR — replaced by Form 44 from TY2026-27.
  • The trap most miss: directly-held AMAT is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
  • If your thesis is "semi-cap-equipment," SOXX or SMH already hold AMAT alongside ASML, LAM, KLA, and Tokyo Electron — same exposure, less single-vendor share-shift risk.

Quick facts

Can an Indian resident buy it?Yes — fully legal under the LRS
Ticker / exchangeAMAT / Nasdaq
HowIndia-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
MinimumA fraction of one share (fractional lets you invest an exact rupee amount)
DividendYes — roughly 1% yield, paid quarterly
US withholding25% under the India-US DTAA via W-8BEN
India tax on gains12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax riskUS-situs above $60k means up to 40%, no treaty relief
Annual complianceSchedule FA disclosure, every year you hold

How to buy it — 3 steps

  1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) for a simple India-funded experience, or a global broker (Interactive Brokers, Rovia) for wider access. File your W-8BEN during onboarding — this drops US dividend withholding from the default 30% to the 25% treaty rate. New to this? Start with how to invest in US stocks from India.
  2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
  3. Place the order. AMAT typically trades in the $170-220 range, so a whole share is affordable for most rupee budgets — or just buy a fractional rupee amount.

The tax that actually matters

Applied Materials pays a small dividend, so two tax buckets apply: a small annual one on the dividend, and a larger one on capital gains when you sell.

Dividends. US withholds 25% at source under the India-US DTAA. The net hits your broker; the gross is taxable in India at your slab. Avoid double taxation by claiming the 25% as Foreign Tax Credit via Form 67, filed before your ITR — being replaced by Form 44 from TY2026-27. At a 1% yield on a 10 lakh rupee position, you're talking ten thousand rupees of dividend a year — the paperwork weight matters more than the rupee amount. Mechanics: dividend withholding and Form 67.

Capital gains. The bigger exposure, under Section 112 (foreign shares don't get the Section 112A treatment Indian-listed equity enjoys):

Holding periodTreatmentRate
24 months or lessShort-termYour slab rate (up to roughly 30% plus surcharge)
More than 24 monthsLong-term12.5%, no indexation

Worked example. Buy 8 shares at $185 when USD/INR is 86 → cost 12,72,800 rupees. Sell 28 months later at $215 when USD/INR is 88 → proceeds 15,13,600 rupees. Taxable gain 2,40,800 rupees; LTCG at 12.5% = 30,100 rupees. The gain is computed in rupees, so a weaker rupee at sale amplifies your reported gain even when the dollar move is modest. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India.

The $60,000 estate-tax trap

Directly-held AMAT is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit or relief. The fix (holding through pooled or fund structures rather than direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get AMAT through an ETF?

If you want…Best route
A concentrated bet that AMAT beats ASML, LAM, KLA, TELAMAT directly
"Semi-cap-equipment cycle wins" exposureSOXX or SMH — AMAT sits alongside the other WFE majors
Broad "US tech / AI infrastructure" exposureQQQ, VTI, or VOO — AMAT is a smaller weight but you get everything else too
The least single-stock and single-node riskA broad semi or tech ETF

AMAT shows up in QQQ, VTI, and VOO as a meaningful but not top-heavy weight, and is a core holding inside semi-themed ETFs like SOXX and SMH — which spread you across ASML, LAM, KLA, Tokyo Electron and the chip designers too. Compare the routes in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader case is in US ETFs for Indians.

The business in one screen

What it is: Applied Materials is the world's largest wafer-fabrication-equipment (WFE) vendor — the toolmaker that sells to the chipmakers. Its products span deposition (CVD, PVD, epitaxy), etch, chemical-mechanical-planarization (CMP), ion implant, and process-control/inspection, plus a growing advanced-packaging franchise (hybrid bonding, through-silicon via). Customers are the leading-edge logic and memory builders — TSMC, Intel, Samsung, SK Hynix, Micron — plus the trailing-edge ICAPS segment (IoT, communications, auto, power, sensors) where AMAT has outsized share. Services and parts are roughly a quarter of revenue and far less cyclical than tool sales.

Bull caseBear case
Broadest WFE portfolio across deposition, etch, CMP, inspectionChina revenue restricted by escalating US export controls
Advanced packaging share gains (hybrid bonding for HBM, chiplets)Equipment-spending is structurally cyclical
Leading-edge logic plus the DRAM-to-HBM transition lifting WFE intensityASML owns lithography; LAM and KLA share etch and inspection at specific nodes
India's Tata-PSMC Dholera fab and Micron Sanand ATMP add incremental demandLeading-edge customer concentration in TSMC, Intel, Samsung
ICAPS (trailing-edge) demand cycle on auto, power, sensors, IoTGross-margin compression risk in the trailing-edge mix

Exact valuation is in the live widget above — a cyclical compounder whose multiple expands and contracts with the WFE cycle.

Our take

Verdict: BUY — the broadest semi-cap-equipment portfolio, real share gains in advanced packaging, and an India fab tailwind that compounds quietly over the next decade.

  • Broadest WFE bench in the industry. AMAT is the only vendor with leadership across deposition, etch, CMP, ion implant, and inspection — meaning when WFE intensity rises (it does at every leading-edge node and at every memory transition), AMAT participates in more dollars per fab than any single-product peer.
  • Advanced packaging is the next leg. Hybrid bonding for HBM stacks, through-silicon vias for chiplets, and heterogeneous integration are all areas where AMAT has been quietly building share. As leading-edge logic transistor scaling slows, packaging-driven performance gains become the dominant lever — and AMAT sits in the middle of that shift.
  • India is incremental, not the thesis — but it helps. The Tata-PSMC Dholera fab, Micron's Sanand ATMP, and Tower's Adani-partnered facility all consume WFE tooling that AMAT, LAM, KLA, ASML and TEL will share. It's not big enough to move the needle on revenue this year, but it adds a multi-year demand tailwind on top of the AI-driven leading-edge cycle.
  • AI capex is sustained, not a spike. Hyperscaler AI spending pulls leading-edge logic at TSMC and HBM at SK Hynix and Micron — both WFE-intensive. AMAT is a downstream beneficiary of every dollar of AI infrastructure capex without taking single-customer concentration risk.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

  • US export controls on China expanding: China has historically been 30-40% of AMAT's mix at various points; further restrictions on advanced tools, or extensions to trailing-edge, can re-rate the stock quickly.
  • Memory capex cyclicality: DRAM and NAND spending swings hard. A memory downturn shows up in AMAT's order book before it shows up in chip prices.
  • Customer concentration at the leading edge: TSMC, Intel, and Samsung together drive the leading-edge WFE budget. A single customer pushing out capex (Intel has done this) can dent a quarter.
  • Gross-margin compression in trailing-edge: the ICAPS franchise is high-volume but lower-margin than leading-edge. Mix shift can pressure reported margins even when revenue grows.
  • Share splits at specific nodes: ASML owns EUV lithography outright; LAM has strength in conductor etch; KLA dominates inspection. AMAT competes node-by-node and tool-by-tool.
  • Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

  • Schedule FA: disclose AMAT in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Use the Schedule FA helper.
  • Position size: a single semi-cap-equipment vendor, however broad its portfolio, is not the cycle. Size AMAT as a thematic satellite alongside a semi or broad-tech ETF, not as a substitute.

Bottom line

Buying AMAT from India is easy and legal. What needs thought isn't the buying — it's that AMAT is a Section-112 capital-gains play (12.5% after 24 months) with a small dividend that triggers 25% US withholding and Form 67 (Form 44 from TY2026-27), a US-situs asset with a $60k estate-tax trap, and a cyclical single name that needs disciplined position sizing. The setup is genuinely good — broadest WFE portfolio, advanced-packaging share gains, AI capex sustained, and India's fab buildout adding incremental demand. If your real thesis is "semi-cap wins," SOXX or SMH gives the same exposure across all the WFE majors. For accounts and options, start at the US investing hub.


This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.

Run your own numbers

Try the calculator that matches this post

Found this useful? Share it.

Help another Indian working with US RSUs or LRS not get blindsided by this stuff.

Share:XLinkedInWhatsApp

About the author

Arnav Grover
Arnav Grover

Co-Founder & Chief Product Officer, Rovia

IIT Bombay + IIM Calcutta. Founding PM at Aspora (NRI fintech). Writes on cross-border investing, payments, and taxation.

More about Arnav

Get more like this in your inbox

One practical post a week on US investing & RSU strategy.